Atara has just announced a CRL by FDA for EBVALLO. EBVALLO is already approved in Europe since December 2022 and the cause of the CRL seems minor and easily addressable. The CRL has a major impact ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback